Minimal Residual Disease in Acute Lymphoblastic Leukemia
2 Pogledi
• 06/15/23
0
0
Ugraditi
administrator
Pretplatnici
The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari